Title: Is Monsanto A Buy At Multi-Year Lows?
1Commodity Trading Research
Is Monsanto A Buy At Multi-Year Lows?
2Welcome to Commodity Trading Research Your
premier site for fundamental and technical
analysis for profitable Commodity Trading. For
more info on Commodity Trading Research visit our
website www.CommodityTradingResearch.com
3- Get Your Free Report On The 3 BEST Commodity
Stocks for 2016! -
- Well tell you about this
- Special Offer
- at the end of the video!
4- Hi, My name is Justin and Im with Commodity
Trading Research, today were reviewing our
recently published article
5- Is Monsanto A Buy At Multi-Year Lows?
6- Without question, Monsanto MONis one of the most
controversial companies in existence.For years
the Agricultural chemical/bio-technology giant
has faced harsh criticism due to their involvement
7- in genetically modified organisms (GMOs). Ill
assume you know what GMOs are (and the
controversy surrounding them), and not waste
precious time explaining that complicated matter
today.
8- Instead, lets discuss Monsantos new problem
9- The companys immensely popular Roundup weed
killer has become the subject of a class-action
lawsuit. Plaintiffs assert Monsanto is
intentionally misleading consumers about the
safety of Roundup.
10- They claim the key ingredient in Roundup,
glyphosate,has links to a host of illnesses,
including cancer and autism.
11- I have to admit, the accusations are a bit
unnerving
12- Roundup is used around homes, gardens, golf
courses, etc.- the world over. Heck, I use it
around my home to kill invasive weeds- and it
does a great job.
13- Monsanto claims directly on the bottle that
glyphosate is safe because it targets an enzyme
in plants that is not present in people or pets.
14- However, a few prominent scientists, along with
the World Health Organization, now disagree with
the companys safety claims.
15- In my opinion, the real bombshell comes from the
factan estimated 100 million tons of Roundup are
sprayed on US corn, soybean, canola, and sugar
beet crops each and every year.
16- Monsantos Roundup Ready GMO crops are designed
to withstand the herbicide while unwanted weeds
shrivel and die. - Heres the deal
17- A recent study reveals glyphosate residue shows
up in human urine tests. Could it be that unless
youre diligent in not eating any GMO sourced
foods(and have been for the past 15 years, when
18- Roundup Ready crops were introduced) youhave
traces of glyphosate floating around in your
body? And if you work with the chemical on an
occupational basis, do you have considerably more?
19- If so, is it a cause for concern?
20- Maybe, maybe not...
- For now it depends on whose research you believe.
Both Monsanto and opposing scientists have reams
of data supporting their arguments.
21- All I know is that as a father of two young
children Im a bit concerned about the issue. At
the very least I wont be using Roundup around my
house until this issue is resolved.
22- But let me be clear about something
- Im not a scientist or any other kind of expert
on Roundup or GMOs. Im just a concerned
consumer wondering if the accusations against
Roundup are true.
23- That brings me to the investment thesis
surrounding the company
24- Once word of this class action suit spreads,
plenty of other consumers will likely rethink
their use of Roundup as well. Its not outlandish
to think Monsantos herbicide sales could decline
25- significantly due to this development- even if a
verdict isnt reached for years (which is likely
the case). Keep in mind, Roundup sales accounted
for roughly 4.8 billion worth of revenues in
fiscal
26- 2015, which is about a third of Monsantos total
sales. Shares of the Ag giant have already taken
quite a hit the past few months. See for yourself
27(No Transcript)
28- MON started diving in June 2015 when investors
realized slowing corn seed sales wouldbe a big
financial headwind going forward.
29- Those worries came to fruitionwhen the company
reportedfiscal fourth-quarter 2015 sales of 2.3
billion- 48 lower than the previous quarter.
30- Due to these lousy results, Monsanto is cutting
2,600 jobs in a restructuring bid. - Heres the question
31- Is MON a good buy at these multi-year low
prices? First of all, the company is trading at
just 14x forward earning, which is cheaper than
Ag rivals Dupont DD, and Sygenta SYT.
32- So if youre interested in investing in a company
thats trying to feed a quickly growing globally
population via GMOs, now may be your time to
strike in MON.
33- Its also important to note the company just
introduced a 3 billion share buyback program.
Clearly, Monsanto thinks its shares are
undervalued at these levels as well.
34- However, you just cant ignore the litigation
risks MON faces going forward
35- Given burgeoning class action lawsuits against
the company,their legal defense expense will
likely rise considerably. That factor mixed with
declining Roundup pricing and sales, and its not
36- out of line to think MON still has more downside
ahead of it. Whats your decision?
37- Personally, Im steering clear of MON until I
see more clarity on the Roundupissue. There are
plenty of other value investment opportunities
out there that dont have huge litigation risks
attached to it.
38- However, I have a feeling most investors will be
more attracted to the value proposition MON
currently provides.
39- Want More from Commodity Trading Research.com?
- Follow us on Social Media
40- Want more FREE information on Commodity Trading?
- Commodity Trading Research.com
DOWNLOAD NOW!
41READ THIS FREE REPORT!
3 HOT Commodity Stocks for 2016 Trading
Success!